More than five million new cases of cancer are diagnosed every year in OECD countries. Mortality rates are declining, but not as fast as for other big killers such as heart disease, and cancer survival rates show almost a four-fold difference across countries. In short, many countries are not doing as well as they could in the fight against cancer.
Cancer Care: Assuring Quality to Improve Survival surveys the policy trends in cancer care over recent years and looks at survival rates to identify the why some countries are doing better than others. It sets out what governments should do to reduce the burden of cancer in their countries. As well as an adequate level of resourcing, a comprehensive national cancer control plan appears critical, emphasising initiatives such as early detection and fast-track treatment pathways. Countries also need better data, particularly for patients’ experiences of care, in order to provide high quality, continuously improving cancer care.
Selon un nouveau rapport de l'OCDE préparé en coopération avec la Commission européenne et fondé sur des travaux antérieurs de l’Organisation mondiale de la santé, un dépistage plus précoce et un traitement plus efficace du cancer pourraient réduire d’un tiers environ le taux de mortalité lié à cette maladie, ce qui permettrait de sauver la vie de près d’un million de personnes dans les pays développés chaque année.
To help inform the Conference on Managing Hospital Volumes, co-organised by the German Federal Ministry of Health and the OECD, and held on the 11th April 2013 in Berlin, the OECD Secretariat produced a paper to provide an international perspective on Germany’s situation and the current policy debate.
The future sustainability of health systems will depend on how well governments are able to anticipate and respond to efficiency and quality of care challenges. Bold action is required, as well as willingness to test innovative care delivery approaches. This book examines the whole new world of possibilities in using mobiles and the Internet to address healthcare challenges.
In Portugal, health spending has been reduced from 10.8% of GDP in 2009 to 10.2% now. This has been achieved by rationalising spending on pharmaceuticals, promoting the use of generic drugs, moderating salaries; cutting the fees paid to hospitals, and increasing user charges, while still protecting those in most need, said OECD Secretary-General.
English, PDF, 108kb
The future of public health: policy decisions today for tomorrow’s populations. Our health, our economy, our society, our future: a Brave New World. Remarks by Yves Leterme, Deputy Secretary-General, OECD. Brussels, Belgium, September 4th 2013.
This report presents the findings of a research project to investigate the drivers and criteria shaping the application of genomic biotechnology to health in different national settings, and the barriers to implementation nationally and internationally. Findings are based on case studies on Finland, Israel, Luxembourg, Mexico, the United Kingdom, China and South Africa.
English, PDF, 1,115kb
Experience from the substantial health gains of the 20th century suggests that spending on prevention could be an important factor. Therefore, gathering data on such spending that are consistent and comparable, both over time and across countries, is potentially very useful. This paper aims to help clarify what should be included as spending on prevention under SHA 2011 to facilitate accurate comparisons.
La Belgique a su se doter de services de santé accessibles, mais le morcellement des responsabilités au sein du système et le poids de la réglementation risquent de rendre l’adaptation au vieillissement de la population difficile.
Après avoir chuté brutalement en 2010, les dépenses de santé ont continué de stagner dans l’ensemble des pays de l’OCDE en 2011, alors que la crise économique continuait de peser notamment sur les pays européens, comme le montre la Base de données de l’OCDE sur la santé 2013.